Objective: Electroconvulsive therapy (ECT) is a safe treatment for psychiatric disorders. As shown after epileptic seizure, mild to moderate respiratory problems could be observed after ECT. We investigated the effects of atropine and aminophylline premedication on respiratory problems that occur after ECT under general anesthesia.
INTRODUCTION
Electroconvulsive therapy (ECT) is a safe and efficient treatment widely used for psychiatric disorders such as major depression, bipolar disorder, and schizophrenia 1 . Electroconvulsive therapy induces seizure activity with electrical stimulation. After electrical stimulus, first a parasympathetic discharge occurs (during the tonic phase) and then an increase in sympathetic activity ensues (during the clonic phase) in the patient's body. Parasympathetic hyperactivity, which is followed by sympathetic activity, may lead to non-serious cardiac instability, hypersecretion, bronchoconstriction, and worsening of oxygenation 2, 3 . Although ECT is a very common and safe procedure, it frequently requires anesthesia outside the operating room. The main goals of anesthesia for ECT include cardiopulmonary and respiratory stability, analgesia, adequate muscle relaxation and amnesia as well as prevention of neurological, cardiopulmonary, and traumatic complications without interfering with ECT efficacy 4 . Mild and short-term hemodynamic respiratory problems can be observed after an ECT procedure similar to those occurring after epileptic seizure 5, 6 . Some respiratory problems such as bronchospasm, crackles, aspiration, and even neurogenic pulmonary edema (NPE) might occur due to an autonomic response to seizure. Postanesthesia complications can also lead to these respiratory problems. Although serious NPE does not occur frequently; short-term, mild to moderate respiratory problems could be observed more often than expected after ECT sessions. In the literature, there are many studies regarding respiratory problems that occur in the post-ictal period in epileptic patients. Nevertheless, there is no study about either incidence or treatment of respiratory problems after ECT procedure.
In the present randomized crossover study, we investigated the incidence of respiratory problems and effects of atropine and aminophylline premedication on respiratory problems that occur after ECT procedure under general anesthesia.
MATERIALS AND METHODS

Ethical Approval
Ethical approval for this study ( in accordance with guidelines of the Helsinki Declaration on Human Subjects and was registered at anzctr.org.au (ACTRN12614000274673). The study protocol was explained in detail to all patients and to their legal representatives, and written informed consents were obtained.
Patient selection criteria and study flow
In total, 88 patients aged 19 to 65 years with an American Society of Anesthesiologists (ASA) score of I-II who had received ECT for the first time between June 2011 and March 2013 at Istanbul Medical Faculty were evaluated for the study. Exclusion criteria were as follows: 1. use of nonbenzodiazepine anticonvulsants (sodium valproate, carbamazepine, lamotrigine, or topiramate), lidocaine, theophylline, or lithium during the last week; 2. neurologic illness or severe medical illness; 3. pregnancy; 4. morbid obesity (BMI>40); 5. hypertension (systolic blood pressure over 160 mm Hg) and /or tachycardia (>90 beats min -1 ); 6. history of stroke, brain surgery; 7. neuromuscular disease; 8. diagnosis of pulmonary disease (COPD, asthma, bronchiectasis, etc.); 9. patients with abnormal respiratory auscultation signs and/or SpO 2 value under 92% before ECT procedure; 10. patients with a symptomatic hiatal hernia or severe gastroesophageal reflux disease. In addition, patients who were unable to reach an adequate seizure time (20 sec.) during any ECT session were excluded from the study. Seventy-six patients who met the inclusion criteria and agreed to participate were signed up, and subsequently 52 patients completed the study (Figure 1 ).
Randomization and Blinding
The present study is a randomized, double-blind crossover trial. All patients had more than three ECT sessions, during the first three of which they entered the study either non-premedicated as part of the Control Group, premedicated with atropine in the Atropine Group, or premedicated with aminophylline in the Aminophylline Group. The order of the patients' assignment to the ECT procedure groups had been determined randomly previously, using the closed envelope method. Thus, each patient was included in every group of the first 3 ECT procedures in different order randomly. Between each ECT session, there was an interval of at least two days (wash-out period). One investigator completed the division of patients into groups, drug preparation and administration. Another investigator collected study data. The investigators did not share information with each other until the end of the study.
Anesthesia and ECT Procedure
Patients were monitored for heart rate (HR) by three-channel electrocardiography; noninvasive blood pressure and peripheral oxygen saturation (SpO 2 ) measurements were taken and a threechannel electroencephalogram (EEG) recorded. A rubber bite block was inserted to prevent dental damage and tongue bite. Ten minutes before anesthesia induction, 5 cc of isotonic saline, 0.01 mg/ kg of atropine (5 cc), and 120 mg aminophylline (5 cc) were given intravenously to the Control Group, Atropine Group, and Aminophylline Group, respectively. Subsequently, anesthesia was induced. During anesthesia induction, propofol was administered over 30 seconds by titration (no less than 1 mg/kg) until the eyelash reflex was lost. When patients became unconscious, the muscle relaxant succinylcholine (0.5 mg/kg) was administered. Patients were ventilated with bag and mask supported with 80% oxygen (6l min -1 ) during the procedure, continued until the patients' full awakening. After adequate a n e s t h e s i a a n d m u s c l e r e l a x a t i o n , electroconvulsive therapy was performed using the Thymatron ® System IV device (Somatics, Inc, Lake Bluff, Ill) with bilateral fronto-temporal electrode placement. Electroconvulsive therapy was administered according to the ECT regulation, in accordance with the guidelines of the American Psychiatric Association and the Royal College of Psychiatrists 7, 8 . Seizure time was defined as the total time between the implementation of electricity until the last seizure seen at the end of the clonic phase (isolated forearm technique was used). The patients were re-stimulated at a higher intensity when seizure duration was less than 20 seconds, in accordance with our institution's treatment protocol. Patients who developed s e r i o u s a n d p e r s i s t e n t h y p e r t e n s i o n (SAP>180mmHg and more than one measurement) during ECT were planned to be treated with esmolol. After ECT, all patients were monitored in the recovery room. Patients were discharged from the recovery room when their vital signs were stable and Modified Aldrete Scores (MAS) were over nine.
Data Collection
The demographics (gender, age, weight) and psychiatric diagnoses of the patients were recorded. Values of each patient's heart rate (HR), systolic artery pressure (SAP), and diastolic artery pressure (DAP) were recorded once before induction of anesthesia and after the ECT procedure (immediately and at 3-minute intervals until patients taken to recovery room). The respiratory sounds were auscultated by the anesthesia physician at four points of the chest (upper right zone, upper left zone, lower right zone and lower left zone) before and after ECT procedure (twice, when spontaneous breathing started). Findings were recorded as normal respiratory sounds, crackles or wheezing. If crackles or wheezing were heard in at least two zones during any auscultation, the patient was defined as generating pathological respiratory sounds. Patients whose SpO 2 values were ≤92% (for at least 5 seconds) were recorded as patients with decreased SpO 2 in the spontaneous ventilation period. The period of time required for recovery of respiratory sounds in patients with abnormal respiratory sounds was recorded. The length of seizures, spontaneous respiration time, and anesthesia recovery time were recorded for each patient, too. In addition, other post-anesthesia complications were recorded. The time between the start of ECT procedure and the re-appearance of adequate spontaneous respiration (5 ml/kg tidal volume by Drager SA-2 with RA2S anesthesia machine) was defined as spontaneous respiration time. Recovery time after anesthesia was defined as the time between the end of the ECT procedure and obtaining a 9 in MAS.
Statistical Analysis
Sample size was calculated according to the pilot study (including 10 patients and 10 ECT procedures per groups) based on the incidence of pathological respiratory sounds after ECT by G Power version 3.1.7. In this pilot study; we found the incidence of pathological respiratory sounds to be 40%, 20%, and 20% for Control Group, Atropine Group, and Aminophylline Group, respectively. According to these findings, a power analysis suggested that at least 49 patients were required to reach an 80% power to detect differences between the study groups with a 0.05 significance level (two-tailed). Results were expressed as mean±standard deviation (SD) or number of patients. All statistical analyses were conducted using SPSS for Windows version 15.0 (SPSS Inc. Chicago, IL, USA). ANOVA, Kruskal-Wallis test and related samples t-test were used for comparison of quantitative variables. Qualitative variables were compared using chisquare tests. Additionally, the Pearson's correlation coefficient and logistic regression analysis were used. p<0.05 was considered statistically significant.
RESULTS
The demographics and psychiatric diagnoses of the patients are given in Table 1 . All HR, SAP, and DAP values were found to be similar between the groups (Table 1) . Within each group, the SAP and DAP values measured immediately after the ECT session were determined to be higher than values measured before induction of anesthesia (p<0.05). We did not observe any persistent hypertension, hence there was no need to use esmolol in any patients. The dosage of propofol and succinylcholine used for anesthesia induction were found to be similar between the groups ( Table 1 ). The observed seizure duration for the Control Group, Atropine Group, and Aminophylline Group were 39.81±18.70 sec, 37.46±17.92 sec, and 40.33±17.41 sec, respectively. There was no statistically significant differences in the duration of seizures between groups (p=0.535).
Respiratory and Recovery Data
The onset of spontaneous breathing after ECT procedure was similar between groups, but the time required to reach an MAS value of 9 was shorter in the Atropine Group compared with the other two groups (Table 2) . When all groups were evaluated together, a weak, statistically significant positive correlation was found between duration of seizure and spontaneous respiration time (r=0.288, p<0.001). The number of patients with low SpO 2 values and abnormal respiratory auscultation signs was lower in the Atropine and Aminophylline Groups. The duration of respiratory full recovery was shorter in the Atropine Group (Table 2) . We found post-operative nausea/vomiting, agitation and shivering rates similar between groups (p>0.05). We did not observe considerable aspiration in any patients after ECT session.
In the Control Group, 8 patients displayed wheezing, 13 patients developed crackles, and in 3 patients wheezing and crackles were observed. One patient in the Control Group had serious and prolonged respiratory problems. This patient was taken to the intensive care unit (ICU) with diagnosis of neurogenic pulmonary edema (NPE). The patient was followed for one day in the ICU (without intubation) and discharged to the psychiatric clinic with cure. Four patients were found with wheezing, 3 patients with crackles, and 2 patients displayed wheezing and crackles in the Atropine Group. Five patients were wheezing, 7 patients had crackles, and 2 had wheezing and crackles in the Aminophylline Group.
We used logistic regression analysis with occurrence of pathological respiratory sounds as a dependent variable, and gender, weight, age of patients, psychotic disorders and duration of seizure as independent variables. This analysis revealed that only longer seizure duration was associated with increased incidence of pathological respiratory sounds (p<0.001, odds ratio=1.23, 95% CI: 1.15 -1.32) (Figure 2) .
DISCUSSION
In the present study, we observed that mild and short-term respiratory problems occurred in 48% of our patients in the Control Group after ECT; we have shown that atropine or aminophylline premedication decreases the incidence of respiratory problems significantly. We also found that longer duration of seizure is a risk factor for respiratory problems.
There are many studies investigating general anesthesia management, hemodynamic problems, and recovery from anesthesia during ECT [9] [10] [11] . However, we have not found any clinical studies investigating respiratory problems after ECT. There are only case reports stating serious respiratory problems such as NPE after ECT. In the present study, we only observed mild and short-term respiratory problems and decreasing SpO 2 values. However, there are case reports about serious respiratory problems such as NPE after ECT in the literature 12, 13 . We encountered a serious and prolonged respiratory problem after only one ECT session (0.06%) during our study period. Respiratory problems after electroconvulsive therapy may be observed in patients due to problems regarding recovery from anesthesia and/ or to seizure itself. It is very challenging to distinguish the factors causing this respiratory problem. We think that those two factors contribute together in most cases. Although the mechanism of respiratory problems after seizure remains unclear, it is thought to be related to increased sympathetic activity after seizures, causing increased blood pressure and increased right ventricle (RV) output due to generalized vasoconstriction 14, 15 . We detected a statistically significant increase in SAP and DAP values in all groups after the ECT procedure. In addition, Tufek et al. found that a rise in blood pressure can be seen frequently after ECT 16 . Increased blood pressure and RV output raise the blood volume in the pulmonary circulation, and thus pulmonary interstitial congestion and/or alveolar edema might develop 15 . Additionally, an idiopathic increase in capillary permeability for unknown reasons can be seen 15. These physiological changes do not always cause severe respiratory problems like NPE. Yet these changes explain the pathophysiology of mild bronchoconstriction and the probability of increased pulmonary secretion after ECT sessions. There are many studies investigating post-ictal respiratory problems in epilepsy patients. These studies focus mostly on apnea attacks observed in the postictal period 17, 18 . However, there are studies stating that respiratory problems and hypoxemia episodes might be present without any signs of apnea 19 . Seizures after ECT might cause respiratory problems even if they are of short duration and not severe. In our control group, we detected that most of the patients developed abnormal respiratory auscultation signs and had slightly lower saturation values after ECT. We found that premedication with atropine and aminophylline decreased the incidence of abnormal respiratory auscultation findings and accelerated their recovery. These respiratory problems have not been seem to cause serious and life-threatening problems and rapidly resolved in all patients. They may however prolong the recovery period and increase potential postanesthetic risks.
We think that the benefit of pre-medication is due to decreased secretions caused by atropine and the bronchodilatory effect of aminophylline. Tang et al. reported that repeated bitemporal ECTs in particular produced bradycardia and an increase in secretion, and they advised the use of anticholinergic pre-medication for suppression of this response 20 . Additionally, the recovery period from anesthesia was shorter in the atropine group. We think this is due to result of decreased incidence of respiratory problems.
Another important point we observed in the present study is that longer duration of seizures is a risk factor for the occurrence of pathologic respiratory sounds, as expected. There are no studies investigating the relationship between the duration of seizures and respiratory problems encountered following ECT. However, similar to our results, there are many studies indicating that the duration of seizures is a risk factor for hypoxia episodes in epilepsy patients in the post-ictal period. Seyal et al. showed that the duration of seizures is a risk factor for low saturation levels observed in the postictal period in a study they conducted on epilepsy patients 19 . Bateman et al. found similar effects when they evaluated the seizures of 52 patients with epilepsy 21 . Seizure time of more than 20 to 25 seconds is usually sufficient for treatment 22 . A seizure duration of more than 120 seconds is recognized as prolonged seizure, which is not desired 8 . However, prior to an ECT procedure we cannot predict how long the seizure duration would be. The increase in the duration of seizures increases the likelihood of respiratory problems.
As a result, mild respiratory problems may occur frequently after ECT and be positively correlated with duration of seizure. While we found a fairly high percentage of respiratory problems, the number of patients in the present study is not sufficient to show the real incidence of respiratory problems after ECT procedure. Therefore, larger groups of patients should be evaluated to determine this incidence. The problems encountered are mostly of short duration and not severe. However, inadequate out-ofoperating-room anesthesia conditions can render these respiratory problems more dangerous. Premedication with atropine or aminophylline before ECT decreases the incidence of pathological respiratory sounds and desaturation. Additionally, according to the data of the present study, atropine is more efficient at reducing respiratory problems. As our study is the first one on this topic, other studies are needed to replicate our findings and support the use of atropine or aminophylline before ECT in terms of reducing the incidence of respiratory problems.
